Peptides design based on the interfacial helix of integrase dimer

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Human immunodeficiency virus type 1 (HIV-1) integrase (IN) is essential for viral replication.
• Peptides derived from IN helices have demonstrated inhibitory potential.
• Targeting IN dimerization is a key strategy for antiviral drug development.

Purpose of the Study:

• To design novel peptides based on HIV-1 IN interface helices alpha1 and alpha5.
• To enhance the inhibitory activity against HIV-1 IN.
• To investigate the structure-activity relationship of designed peptide inhibitors.

Main Methods:

• Molecular dynamics (MD) simulations to predict peptide stability and conformational preferences.
• AGADIR algorithm for predicting helix-forming propensity.
• Binding free energy calculations to assess peptide-IN affinity.
• Analysis of binding modes between designed peptides and HIV-1 IN.

Main Results:

• Designed peptides based on alpha1 and alpha5 helices exhibited favorable helix-forming tendencies and IN affinity.
• MD simulations and AGADIR predictions supported the design strategy.
• Binding free energy analysis indicated improved inhibitory potential compared to native helices.
• Some designed peptides demonstrated enhanced inhibition of IN dimerization.

Conclusions:

• Rational design of peptides targeting HIV-1 IN interface helices is feasible.
• The designed peptides show potential as novel inhibitors of HIV-1 IN dimerization.
• This study offers valuable insights for developing effective peptide-based HIV-1 inhibitors.